DAY ONE - Monday 6th September 2010

08:30 Registration and coffee

09:00 Current trends in longevity

  • Developments in the past
  • How sustainable are current trends?
  • The impact of medical developments
  • Pandemics and infectious diseases
  • Impact of data availability on forecasts

Dr Michaela Grimm, Senior Economist, ALLIANZ SE

10:30 Morning break

11:00 The impact of Solvency II on longevity risk

  • The impact of longevity swaps
  • Which products will be most effective under Solvency II?
  • What are the shocks and sensitivity stresses?
  • Estimating economic capital requirements

Tiziana Torri, R&D Actuary, SCOR

12:30 Lunch

13:30 Playing the numbers game: using data to predict mortality

    • Current approaches to estimating life expectancy
    • Importance of risk factors and treatment to future mortality
    • Availability of national and international data sources
    • Illustration of mortality forecasts under different approaches
    • Extrapolation of past trends
    • Use of target long term assumptions
    • Predictions based on scenario analysis
    Steven Baxter, Longevity Consultant, CLUB VITA LLP

    15.00 Afternoon break

    15.30 Deterministic shock vs. stochastic value-at-risk: an analysis of the Solvency II standard model approach to longevity risk

    • Analysis of the standard model longevity shock by comparing the resulting capital requirement to the value-at-risk based on a stochastic mortality model
    • Modification of the longevity shock such that it accounts for the risk more adequately
    • Analysis of different risk margin approximations
    • Comment on the current cost of capital rate by a comparison with possible market prices of longevity risk
    • Relation of prices for longevity derivatives to solvency capital requirements
    Matthias Boerger, Researcher & Actuarial Consultant, ULM UNIVERSITY & IFA ULM

    17:00 End of day one

    DAY TWO - Tuesday 7th September 2010

    08:30 Registration and coffee

    09:00 Transferring longevity risk

    • How is it possible to transfer the risk?
    • Which risks are covered and which are not?
    • How to manage non-covered risks
    • Structures available to transfer longevity risk: comparing swaps, bonds and reinsurance structures
    • Choosing an appropriate reference portfolio
    • Longevity indices and index-based hedging
    David Epstein, Executive Director, J.P. MORGAN

    10:30 Morning break

    11:00 Managing longevity risk in pension schemes - a practical perspective

    • Evolution of the longevity swap market
    • Understanding longevity risk
    • Today's longevity hedging market
    • Practical considerations and trustee thinking

    Philip Simpson, Principal and Consulting Actuary, MILLIMAN

    Farzana Ismail, Consulting Actuary, MILLIMAN

    12:30 Lunch

    13:30 The LLMA and Longevity Index

    • Principles of Longevity Index
    • Data sources
    • Method
    • How the index relates to the longevity risk market
    • Other issues
    Joseph Lu, Mortality Risk Actuary, LEGAL & GENERAL

    15:00 Afternoon break

    15:30 Stochastic mortality modelling

    • Obtaining biologically plausible forecasts
    • Modelling related populations
    • Frailty models
    • Short-term deviations from long-term trends
    • Sources of uncertainty

    Soren Fiig Jarner, Chief Scientific Officer, ATP

    17:00 End of the course